Relay Therapeutics Inc. Common Stock vs XPO Inc. Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.27 (market cap $3.82B), while XPO Inc. Common Stock trades at $181.78 (market cap $21.30B). The key difference: XPO Inc. Common Stock is far larger — about 5.6× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, XPO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and XPO Inc. Common Stock for 1 Days on average.
| RLAY | XPO | |
|---|---|---|
Market Cap | $3.82B | $21.30B |
Volume | 4,332,079 | 897,705 |
Sector | Health | Industrials |
52-Week High | $20.75 | $228.37 |
52-Week Low | $6.03 | $123.66 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $2.93B | $24.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →